Understand the key differences between pellets and granules in pharmaceutical applications. Learn when to use each for optimal formulation results.
R
Rraynex Editorial Team
3 min read
Updated
Overview
The terms "granule" and "pellet" are frequently used interchangeably in pharmaceutical manufacturing, but to a formulator, they refer to two different drug delivery systems.
Pellets and granules can contain active ingredients and excipients. Evaluate each for its physical characteristics, target release profile and intended downstream process.
The distinctions between pellets and granules are explained in this formulator's guide.
Granules are agglomerated particles. Granulation can help manage powder handling, flow and compaction. The required properties depend on the material and the downstream process.
Pellets: What Are They?
Pellets are discrete, typically rounded units. They can be coated to develop a release profile and incorporated into a finished dosage form such as a capsule. A tablet project may also use pellets as part of a multiparticulate system.
When Formulators Evaluate Pellets
For a multiparticulate formulation, evaluate whether individual coated units meet the release and handling objectives.
A. Ideal Coating Surface
Pellet size and shape influence surface area and coating. Ask how the proposed material will be evaluated for coating integrity and consistency.
Enteric coating and sustained release have different test objectives. Review the proposed specification for the relevant conditions and acceptance criteria.
Assess the actual material and coating process when comparing release or handling performance.
B. Multiparticulate Release Testing
A multiparticulate formulation contains multiple units. Qualification should evaluate both the proposed material and the finished formulation.
Release assessment: Evaluate performance against the actual formulation and its release specification. The use of pellets alone does not establish a particular safety outcome.
C. Combination Treatments
Some combination formulation designs use separate pellet populations. Chemical compatibility, content uniformity and release need product-specific evaluation.
Use the intended combination, active content for each component and test criteria when discussing the design with a formulation team.
When Granules Should Be Used
When selecting a granule for tableting, assess powder handling, flow, compaction and the required finished-tablet tests.
Process choice: Compare wet and dry granulation and direct-compression options against the formulation and equipment requirements.
Direct compression: For a Metformin HCl DC Granules enquiry, include the target loading, uncoated tablet weight and planned press conditions where known.
Rraynex: Getting the Most Out of Both Technologies
The appropriate material depends on the formulation, process and required specification.
Granules: Include your target quantity and tableting requirements in the enquiry.
Pellets: Include the intended downstream process and the release requirements.
Final Decision
For tablet development, choose the material using the intended formulation, process and acceptance criteria. Compare pharmaceutical granule catalogue references when preparing a sourcing enquiry.
Evaluate pellets when a multiparticulate form fits the intended dosage design. Confirm the release criteria through product-specific assessment.
Are You Unsure of the Best Dosage Form for Your New Molecule?
For advice on formulation strategy, get in touch with Rraynex.
Frequently Asked Questions
How should buyers choose between pellets and granules?
Evaluate the intended dosage form, release requirements and downstream operations. Selection should be based on development data and product-specific specifications.
Can a material be substituted using its category name alone?
No. Confirm composition, strength, physical characteristics, release performance and suitability for the intended process before considering a substitution.
Put insight into practice
Let’s discuss your next formulation project.
Share your product, strength, release requirements, expected quantity and destination market with our team.
A guide to pharmaceutical pellets for formulators. Learn about pelletisation, release designations and what to confirm when evaluating a pellet specification.
Discover why APIs are the backbone of every drug formulation. Learn about the critical role of API quality, physical attributes, and how they impact therapeutic success.
Explore pharmaceutical pellet and DC granule manufacturing, pilot-to-commercial scale-up, process validation, formulation development and bulk supply planning in India.